Movement Alert｜WuXi XDC Falls 3.02% in Regular Trading, Buyback Fails to Halt Slide as Geopolitical Headwinds Pressure WuXi Group

Market Focus

Jun 16

On June 16, WuXi XDC fell 3.02% in regular trading, trading at HK$47.1/share with turnover of HK$82.71 million, extending a multi-session decline that has pushed the stock more than 17% below its buyback average price of HK$57.3.

The continued weakness comes amid persistent sector pressure following the US Department of Defense listing parent group affiliate WuXi AppTec on its 1260H Chinese Military Companies list. WuXi AppTec has since filed a lawsuit in US federal court challenging the designation, but market uncertainty remains elevated. The broader WuXi system deployed approximately US$500 million in combined buybacks, including HK$327 million by WuXi XDC's trustee at an average price of HK$57.3, yet the intensive repurchases have failed to reverse selling pressure. Southbound funds recorded net selling for five consecutive sessions recently, reducing holdings by 3.63 million shares over that period.

Within the Life Sciences Tools and Services sector, WuXi Biologics fell 2.01%, XtalPi fell 3.31%, GenScript Biotech fell 2.71%, and Insilico Medicine fell 4.40%, while WuXi AppTec edged up 0.24%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1156197967"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156197967\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156197967?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 10:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156197967","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Falls 3.02% in Regular Trading, Buyback Fails to Halt Slide as Geopolitical Headwinds Pressure WuXi Group","media":"Market Focus","content":"<p><p>On June 16, WuXi XDC fell 3.02% in regular trading, trading at HK$47.1/share with turnover of HK$82.71 million, extending a multi-session decline that has pushed the stock more than 17% below its buyback average price of HK$57.3.</p><p>The continued weakness comes amid persistent sector pressure following the US Department of Defense listing parent group affiliate WuXi AppTec on its 1260H Chinese Military Companies list. WuXi AppTec has since filed a lawsuit in US federal court challenging the designation, but market uncertainty remains elevated. The broader WuXi system deployed approximately US$500 million in combined buybacks, including HK$327 million by WuXi XDC's trustee at an average price of HK$57.3, yet the intensive repurchases have failed to reverse selling pressure. Southbound funds recorded net selling for five consecutive sessions recently, reducing holdings by 3.63 million shares over that period.</p><p>Within the Life Sciences Tools and Services sector, WuXi Biologics fell 2.01%, XtalPi fell 3.31%, GenScript Biotech fell 2.71%, and Insilico Medicine fell 4.40%, while WuXi AppTec edged up 0.24%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Falls 3.02% in Regular Trading, Buyback Fails to Halt Slide as Geopolitical Headwinds Pressure WuXi Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Falls 3.02% in Regular Trading, Buyback Fails to Halt Slide as Geopolitical Headwinds Pressure WuXi Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-16 10:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 16, WuXi XDC fell 3.02% in regular trading, trading at HK$47.1/share with turnover of HK$82.71 million, extending a multi-session decline that has pushed the stock more than 17% below its buyback average price of HK$57.3.</p><p>The continued weakness comes amid persistent sector pressure following the US Department of Defense listing parent group affiliate WuXi AppTec on its 1260H Chinese Military Companies list. WuXi AppTec has since filed a lawsuit in US federal court challenging the designation, but market uncertainty remains elevated. The broader WuXi system deployed approximately US$500 million in combined buybacks, including HK$327 million by WuXi XDC's trustee at an average price of HK$57.3, yet the intensive repurchases have failed to reverse selling pressure. Southbound funds recorded net selling for five consecutive sessions recently, reducing holdings by 3.63 million shares over that period.</p><p>Within the Life Sciences Tools and Services sector, WuXi Biologics fell 2.01%, XtalPi fell 3.31%, GenScript Biotech fell 2.71%, and Insilico Medicine fell 4.40%, while WuXi AppTec edged up 0.24%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1156197967","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156197967","pubTimestamp":1781576587,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 16, WuXi XDC fell 3.02% in regular trading, trading at HK$47.1/share with turnover of HK$82.71 million, extending a multi-session decline that has pushed the stock more than 17% below its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动态警报|无锡XDC常规交易下跌3.02%，地缘政治逆风给无锡集团带来压力，回购未能阻止下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On June 16, WuXi XDC fell 3.02% in regular trading, trading at HK$47.1/share with turnover of HK$82.71 million, extending a multi-session decline that has pushed the stock more than 17% below its buyback average price of HK$57.3.The continued weakness comes amid persistent sector pressure following the US Department of Defense listing parent group affiliate WuXi AppTec on its 1260H Chinese Military Companies list. WuXi AppTec has since filed a lawsuit in US federal court challenging the designation, but market uncertainty remains elevated. The broader WuXi system deployed approximately US$500 million in combined buybacks, including HK$327 million by WuXi XDC's trustee at an average price of HK$57.3, yet the intensive repurchases have failed to reverse selling pressure. Southbound funds recorded net selling for five consecutive sessions recently, reducing holdings by 3.63 million shares over that period.Within the Life Sciences Tools and Services sector, WuXi Biologics fell 2.01%, XtalPi fell 3.31%, GenScript Biotech fell 2.71%, and Insilico Medicine fell 4.40%, while WuXi AppTec edged up 0.24%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}